Document:

QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.13    
  

         BOISE CASCADE CORPORATION

SUPPLEMENTAL HEALTHCARE PLAN FOR EXECUTIVE OFFICERS

Amended January 1, 2003  

   SUPPLEMENTAL HEALTHCARE PLAN FOR EXECUTIVE OFFICERS  

INTRODUCTION

Boise
Cascade Corporation (the "Company") has adopted a Supplemental Healthcare Plan for Executive Officers (the "Plan") in addition to the Medical, Dental, and Vision Programs (the "Healthcare
Programs") available under the Company's Comprehensive Welfare Benefit Plan. While you share in the cost of your medical care by paying a monthly contribution, a deductible, and a percentage of the
remaining expenses, the combination of the plans pays most of the major charges for covered healthcare expenses for you and your dependents. 

WHO
IS ELIGIBLE 

As
an executive officer of the Company, you are automatically eligible for coverage under the Plan. Your dependents' coverage under the Plan will become effective on the same date that your own
coverage begins. 

Your
dependents who are eligible for coverage under this Plan include your spouse plus any unmarried children under age 23, if they do not regularly work full-time and are dependent on you
for support. Under certain circumstances, a child with disabilities may be covered beyond age 23. 

HOW
BENEFITS BECOME PAYABLE 

Medical,
dental, and vision benefits become payable under this Plan after benefits for covered charges under the Healthcare Programs have been applied to medical, dental, or vision expenses incurred
by you or your covered dependent. The Plan will pay 100% of the remaining charges for the treatment, services, and supplies listed under "What the Plan Covers." Amounts applied to the deductible and
copayments under the Healthcare Programs are not covered under this Plan. 

The
deductible and copayment amounts under the Prescription Drug Program are not covered under this Plan. 

WHAT
THE PLAN COVERS 

Medical
expenses incurred will be reduced by the amount considered as covered charges under the Medical Program. The Plan will pay 100% of the remaining charges for the following medical expenses: 

	•
	Hospital
room and board charges. 
	•
	Hospital
intensive care (ICU) and cardiac care unit (CCU) charges. 
	•
	Hospital
services and supplies (inpatient or outpatient). 
	•
	Medical
treatment or surgery by a physician. 
	•
	Outpatient
surgical facility services and supplies. 
	•
	Private-duty
nursing by a registered nurse (R.N.), a licensed vocational nurse (L.V.N.), or a licensed practical nurse (L.P.N.) upon the written
recommendation of a physician. 
	•
	Ambulance
service. 
	•
	Immunizations.

	•
	Anesthetics
and oxygen and their administration. 
	•
	Rental
or purchase (at the Company's option) of approved durable medical equipment and appliances. 
	•
	Physical
therapy by a licensed physiotherapist for treatment by physical or mechanical means only. 
	•
	Outpatient
rehabilitative speech and occupational therapy. Care must be provided by a licensed therapist who is referred and supervised by a licensed
physician. 
	•
	Blood
and blood plasma which are not replaced by donation, and their administration. 
	•
	Diagnostic
x-rays and laboratory tests. 
	•
	Extended-care
facility confinement, including services and supplies. 
	•
	Medical
social services while a patient is in an extended-care facility. 
	•
	Psychiatric
care provided by a physician. 

2

 

	•
	Mammograms.

The
Plan will also pay 100% of the remaining charges for vision exams, eyeglasses, contact lenses, hearing aids, and dental expenses (including orthodontia and expenses for repair and maintenance of
covered items) after benefits under the Healthcare Programs have been applied. 

WHAT
THE PLAN DOES NOT COVER 

Expenses
for items shown in the list that follows are not covered under the Plan: 

	•
	Injury
or illness resulting from war or an act of war, whether declared or undeclared. 
	•
	Items
payable by workers' compensation or any other government program. 
	•
	Items
for which no charge would have been made in the absence of medical coverage, or items for which you are not legally obligated to pay. 
	•
	Prescription
drugs obtained through the Company's Prescription Drug Program. 
	•
	Items
for which the Company, by law or regulation, may not provide benefits. 
	•
	Medical
services rendered prior to the date your coverage by this Plan began. 
	•
	Charges
which are applied to the deductible and copayments under the Healthcare Programs. 

HEALTH
CARE CLAIMS 

The
necessary forms to file a claim for covered health care expenses under this Plan are available from HR Services in Boise, Idaho, telephone 1-800-237-3459
or (208) 384-7172. 

PLAN
ADMINISTRATION, ERISA RIGHTS 

The
Your Health Benefits booklet (the summary plan description) identifies the Plan administrator and explains your ERISA rights under this Plan. If a
dispute or disagreement arises regarding terms of coverage or benefits provided under this Plan, you must use the claims/appeal processes described in that booklet. 

CONTINUATION
OF COVERAGE/QUALIFIED MEDICAL CHILD SUPPORT ORDERS 

The
Plan is subject to the requirements of federal law as they relate to continuation of medical benefits pursuant to provisions of the Consolidated Omnibus Budget Reconciliation Act of 1985 ("COBRA")
and to "Qualified Medical Child Support Orders" under the Omnibus Budget Reconciliation Act of 1993. These requirements are described in more detail in the Your Health
Benefits booklet. 

SOURCE
OF FUNDING 

This
Plan is self-insured by the Company. Payments for benefits under this Plan are made from the general assets of the Company as benefits become payable. 

TAXABILITY 

All
benefits payable under this Plan are considered taxable income to you, are subject to tax withholding requirements, and will be reflected in your Form W-2 earnings. 

COVERAGE
DURING A LEAVE OF ABSENCE 

Your
medical coverages may be continued while you are still employed by the Company but are not actively at work because of an accident or illness or certain other company-approved leaves of absence.
Under such conditions, coverage will continue in keeping with the provisions of the leave. 

WHEN
YOUR COVERAGE ENDS 

Your
coverage under the Plan ends on the earliest of the following dates: 

	•
	On
the date your employment with the Company ends. 
	•
	On
the date you become ineligible to participate in these coverages—for example, if you cease to be an executive officer of the Company. 
	•
	On
the date the Company elects to discontinue this Plan. 

3

 

WHEN
YOUR DEPENDENTS' COVERAGE ENDS 

Your
dependents' coverage under this Plan ends on the earliest of the following dates: 

	•
	On
the date your coverage ends. 
	•
	On
the date your dependent ceases to be eligible because of a change in age or dependent status as defined under the specifically named medical plan. 
	•
	On
the date your dependent begins active duty in the armed forces of any country, state, or international organization. 
	•
	On
the date the Company elects to discontinue this Plan. 

The Company expressly reserves the right to amend or terminate this Plan at any time. Coverage under this Plan is not and should not be deemed to create a contract of
employment and under no circumstances shall be construed to give any participant a right to remain an employee or officer of the Company for any period. Any participant in this Plan is employed solely
at the will of the Company.

To the extent not governed by federal law, this Plan will be construed according to the laws of the state of Idaho. In the event any lawsuit or legal action is brought (by any
party, person, or entity regarding this Plan,
benefits hereunder, or any related issue), such action or suit may be brought only in Federal District Court in the District of Idaho.

4

QuickLinks

Exhibit 10.13QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.19    
  

         BOISE CASCADE CORPORATION

DIRECTOR STOCK COMPENSATION PLAN

(As Amended Through December 12, 2002)  

BOISE CASCADE CORPORATION

DIRECTOR STOCK COMPENSATION PLAN  

        1.    Plan Administration and Eligibility. 

                1.1    Purpose.    The purpose of the Director Stock Compensation Plan (the "Plan") of Boise Cascade Corporation (the
"Company") is to encourage ownership of the Company's common stock by its nonemployee directors. 

                1.2    Administration.    The Executive Compensation Committee or any successor to the Committee (the "Committee")
shall have final discretion, responsibility, and authority to administer and interpret the Plan. This includes the discretion and authority to determine all questions of fact, eligibility, or benefits
relating to the Plan. The Committee may also adopt any rules it deems necessary to administer the Plan. The Committee's responsibilities for administration and interpretation of the Plan shall be
exercised by Company employees who have been assigned those responsibilities by the Company's management. Any Company employee exercising responsibilities relating to the Plan in accordance with this
section shall be deemed to have been delegated the discretionary authority vested in the Committee with respect to those responsibilities, unless limited in writing by the Committee. Any Participant
may appeal any action or decision of these employees to the Company's General Counsel and may request that the Committee reconsider decisions of the General Counsel. Any interpretation by the
Committee shall be final and binding on the Participants. 

                1.3    Participation in the Plan.    Directors of the Company who are not employees of the Company or any of its
subsidiaries are eligible to participate in this Plan. 

        2.    Stock Subject to the Plan. 

                2.1    Number of Shares.    The maximum number of shares of the Company's $2.50 par value Common Stock ("Common
Stock" or "Shares") which may be issued pursuant to options granted under this Plan shall be 100,000 Shares, subject to adjustment as provided in Section 4.4. 

                2.2    Nonexercised Shares.    If any outstanding option under this Plan for any reason expires or is terminated
without having been exercised in full, the Shares allocable to the unexercised portion of the option shall again become available for issuance under options granted pursuant to this Plan. 

                2.3    Share Issuance.    Upon the exercise of an option, the Company may issue new Shares or reissue Shares
previously repurchased by or on behalf of the Company. 

        3.    Options. 

                3.1    Option Grant Dates.    Options shall be granted automatically to each participating director on
December 31 of each year (or, if December 31 is not a business day, on the immediately preceding business day) (the "Grant Date"). 

                3.2    Option Price.    The purchase price per share for the Shares covered by each option shall be $2.50 (the
"Option Price"). 

                3.3    Number of Option Shares.    The number of Shares subject to options granted to each participating director on
each Grant Date will be the aggregate number of Shares determined by the following formulas: 

                        3.3.1    Elected Portion of Annual Retainer and Meeting Fee Shares.    The number of option Shares equal to the
nearest whole number determined by the following formula: 

	Elected Portion of Annual Retainer

and Meeting Fees
 (Fair Market Value - $2.50)	 	

=	 	Number

of

Option Shares

 

                        3.3.2    Dividend Equivalent Shares.    The number of option Shares equal to the nearest whole number determined by
the following formula: 

	Dividend Equivalent
 (Fair Market Value - $2.50)	 	

=	 	Number

of

Option Shares

                        3.3.3    Definitions.    For purposes of determining the number of Shares granted under this Section 3.3, the
following definitions will apply: 

                                    3.3.3.1   
 "Annual Retainer."    The dollar amount of compensation paid to eligible directors each year which is
identified by the Company as an annual retainer. 

                                    3.3.3.2   
 "Meeting Fees."    The amount of compensation, in excess of the Annual Retainer, paid to eligible
directors for their services as directors of the Company, including but not limited to fees earned for service as committee chairpersons and for meeting participation, but excluding amounts paid as
reimbursement for actual expenses. 

                                    3.3.3.3   
 "Dividend Equivalent."    The aggregate dollar value, determined each year,
equal to the product of (i) the number of Shares subject to options held by a director pursuant to this Plan on each respective Record Date during the year plus 1/2 the number of
Shares to be granted under Sections 3.3.1 and 3.3.2
for the year in which this calculation is being made, multiplied by (ii) the value of the dividend per Share paid by the Company for each respective Record Date. 

                                    3.3.3.4   
 "Elected Portion of Annual Retainer and Meeting Fees."    A dollar amount
determined each year for each director equal to the dollar amount of both the percentage of the Annual Retainer, if any, and the percentage of Meeting Fees, if any, which the director has irrevocably
elected, in writing, to have paid in the form of options granted under this Plan. This written election must be received by the secretary of the Company on or before December 31 of each year
and shall specify a percentage, up to 100%, of the director's Annual Retainer and a percentage, up to 100%, of the director's Meeting Fees for the following year to be paid in the form of options
under this Plan; provided, however, in the initial year of the Plan's operation, a director's written election must be received by the secretary of the Company on or before February 28, 1992,
and shall be effective only for Annual Retainer and Meeting Fee amounts earned during the period April 1, 1992, through December 31, 1992. Eligible directors initially elected or
appointed to office as directors of the Company after adoption of this plan may make a written election under this paragraph within 30 days following their initial election or appointment to
office, which election shall be effective for Annual Retainer and Meeting Fee amounts earned during the calendar year of their initial election or appointment to office. 

                                    3.3.3.5   
 "Fair Market Value."    The closing price for Shares as reported by the New
York Stock Exchange or another generally accepted pricing standard chosen by the Company, in each case on the Valuation Date. 

                                    3.3.3.6   
 "Record Date."    Each date declared as a record date by the Board of
Directors for the purpose of determining shareholders eligible to receive a dividend to be paid on Shares. 

                                    3.3.3.7   
 "Valuation Date."    July 31, or if Fair Market Value is not available
on July 31, the immediately preceding business day for which Fair Market Value is available. 

                3.4    Director Terminations.    If a director participating in this Plan retires, resigns, dies, or otherwise
terminates his or her position on the Company's Board of Directors, on December 31 of the year in which the termination occurs the director shall be granted an option for Shares under this Plan
equal in value to (i) the Elected Portion of Annual Retainer and Meeting Fees and (ii) the Dividend 

2

 

Equivalent. For purposes of this Section 3.4, the amount of the Annual Retainer shall be prorated through the date of termination. 

                3.5    Written Agreements.    Each grant of an option under this Plan shall be evidenced by a written agreement,
which shall comply with and be subject to the terms and conditions contained in this Plan. 

                3.6    Nonstatutory Stock Options.    Options granted under this Plan shall not be entitled to special tax treatment
under Section 422A of the Internal Revenue Code of 1986. 

                3.7    Period of Option.    No option may be exercised within 6 months of its Grant Date, provided, however,
that options held by a director shall be immediately exercisable upon (i) that director's retirement because of age, disability, or death, or (ii) the occurrence of any of the events
described in Section 3.11, [recognizing that Rule 16b-3 under the Securities Exchange Act of 1934, as amended (the "Act"), may limit a director's ability to
resell the Shares acquired upon the exercise until 6 months after the Grant Date]. No option shall be exercisable after expiration of 3 years from the date upon which the
option holder terminates his or her position as a director of the Company. 

                3.8    Exercise of Options.    Options may be exercised only by written notice to the secretary of the Company and
payment of the exercise price in (i) cash, (ii) Shares (a director may surrender one or more Shares in the exercise of an Option with instructions to resurrender any Shares acquired upon
exercise in one or more successive, simultaneous exercises until Options covering the number of specified Shares have been exercised), (iii) a loan from the Company, or (iv) delivery of
an irrevocable written notice instructing the Company to deliver the Shares being purchased to a broker, subject to the broker's written guarantee to deliver cash to the Company, in each case equal to
the full consideration of the Option Price for the Shares which are being exercised. Options may be exercised in whole or in part. 

                3.9    Options Not Transferable.    Each option granted under this Plan shall not be transferable by the optionee
otherwise than by will or by the laws of descent and distribution or pursuant to a qualified domestic relations order as defined by the Internal Revenue Code of 1986, as amended, or Title I of the
Employee Retirement Income Security Act of 1974, as amended, and the rules and regulations thereunder. No option granted under this Plan, or any interest therein, may be otherwise transferred,
assigned, pledged, or hypothecated by the director to which the option was granted during his or her lifetime, whether by operation of law or otherwise, or be made subject to execution, attachment, or
similar process. 

                3.10    Exercise by Representative Following Death of Director.    A director, by written notice to the Company, may
designate one or more persons (and from time to time change such designation), including his or her legal representative, who, by reason of the director's death, shall acquire the right to exercise
all or a portion of an option granted under this Plan. Any exercise by a representative shall be subject to the provisions of this Plan. 

                3.11    Acceleration of Stock Options.    Notwithstanding Section 3.7, if, while unexercised options remain
outstanding hereunder: 

                                (a)    Any
Person is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing 20% or more of either the then outstanding shares of
common stock of the Company or the combined voting power of the Company's then outstanding securities; provided, however, if such
Person acquires securities directly from the Company, such securities shall not be included unless such Person acquires additional securities which, when added to the securities acquired directly from
the Company, exceed 20% of the Company's then outstanding shares of common stock or the combined voting power of the Company's then outstanding securities, and provided further that any acquisition of
securities by any Person in connection with a transaction described in Subsection 3.11(c)(i) shall not be deemed to be a change in control of the Company; or 

3

 

                                (b)    The
following individuals cease for any reason to constitute at least 662/3% of the number of directors then serving: individuals who, on the date
hereof, constitute the Board and any new director (other than a director whose initial assumption of office is in connection with an actual or threatened election contest, including but not limited to
a consent solicitation, relating to the election of directors of the Company) whose appointment or election by the Board or nomination for election by the Company's stockholders was approved by a vote
of at least 2/3rds of the directors then still in office who either were directors on the date hereof or whose appointment, election, or nomination for election was previously so approved (the
"Continuing Directors"); or 

                                (c)    The
consummation of a merger or consolidation of the Company (or any direct or indirect subsidiary of the Company) with any other corporation other than (i) a
merger or consolidation which would result in both (a) continuing directors continuing to constitute at least 662/3% of the number of directors of the combined entity immediately
following consummation of such merger or consolidation and (b) the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either
by remaining outstanding or by being converted into voting securities of the surviving entity or any parent thereof) at least 662/3% of the combined voting power of the voting
securities of the Company or such surviving entity or any parent thereof outstanding immediately after such merger or consolidation, or (ii) a merger or consolidation effected to implement a
recapitalization of the Company (or similar transaction) in which no Person is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing 20% or more of either
the then outstanding shares of common stock of the Company or the combined voting power of the Company's then outstanding securities; provided, however, if such Person acquires securities directly
from the Company, such securities shall not be included unless such Person acquires additional securities which, when added to the securities acquired directly from the Company, exceed 20% of the
Company's then outstanding shares of common stock or the combined voting power of the Company's then outstanding securities, and provided further that any acquisition of securities by any Person in
connection with a transaction described in Subsection 3.11(c)(i) shall not be deemed to be a change in control of the Company; or 

                                (d)    The
stockholders of the Company approve a plan of complete liquidation or dissolution of the Company or the consummation of an agreement for the sale or disposition by
the Company of all or substantially all of the Company's assets, other than a sale or disposition by the Company of all or substantially all of the Company's assets to an entity, at least
662/3% of the combined voting power of the voting securities of which are owned by Persons in substantially the same proportions as their ownership of the Company immediately prior to
such sale; 

then
from and after the date on which any such event described in paragraphs (a) through (d) above occurs (which shall constitute a "change in control" of the Company), all options
previously granted under this Plan shall be immediately exercisable in full. 

                                For
purposes of this section, "Beneficial Owner" shall have the meaning set forth in Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the "Exchange
Act"). 

                                For
purposes of this section, "Person" shall have the meaning given in Section 3(a)(9) of the Exchange Act, as modified and used in Sections 13(d) and 14(d) thereof, except that
such term shall not include (i) the Company or any of its subsidiaries, (ii) a trustee or other fiduciary holding securities under an employee benefit plan of the Company or any of its
subsidiaries, (iii) an underwriter temporarily holding securities pursuant to an offering of such securities, or (iv) a corporation owned, directly or indirectly, by the stockholders of
the Company in substantially the same proportions as their ownership of stock of the Company. 

        4.    General Provisions. 

4

 

                4.1    Effective Date of This Plan.    This Plan shall be effective January 1, 1992, subject to approval by
the shareholders of the Company. Options may be granted under this Plan only after shareholder approval of this Plan. Directors may give written notice pursuant to Subsection 3.3.3.4 any time after
December 1, 1991. 

                4.2    Duration of This Plan.    This Plan shall remain in effect until all Shares subject to option grants have been
purchased or all unexercised options have expired. Notwithstanding the foregoing, no options may be granted pursuant to this Plan on or after January 1, 2003. 

                4.3    Amendment of This Plan.    The Committee may suspend or discontinue this Plan or revise or amend it in any
respect, provided, however, that without approval of a majority of the Company's shareholders no revision or amendment shall (i) change the number of Shares subject to this Plan (except as
provided in Section 4.4), (ii) change the designation of the class of directors eligible to participate in the Plan, (iii) change the formulas to determine the amount, price, or
timing for the grants, or (iv) materially increase the benefits accruing to participants under this Plan. Moreover, in no event may these Plan provisions be amended more than once every
6 months, other than to comport with changes in the Internal Revenue Code, the Employee Retirement Income Security Act, or the rules and regulations thereunder. No amendment, modification, or
termination of this Plan shall in any manner adversely affect the rights of directors holding options granted under this Plan without their consent. 

                4.4    Changes in Shares.    In the event of any merger, consolidation, reorganization, recapitalization, stock
dividend, stock split, or other change in the corporate structure or capitalization affecting the Shares, appropriate adjustment shall be made in the number (including the aggregate numbers specified
in Section 2.1) and kind of Shares or other securities which are or may become subject to options granted under this Plan prior to and subsequent to the date of the change. 

                4.5    Limitation of Rights. 

                        4.5.1    No Right to Continue as a Director.    Neither this Plan, nor the granting of an option under this Plan, nor
any other action taken pursuant to this Plan shall constitute or be evidence of any agreement or understanding, express or implied, that the Company will retain a director for any period of time, or
at any particular rate of compensation. 

                        4.5.2    No Shareholders' Rights for Options.    An optionee shall have no rights as a shareholder with respect to
the Shares covered by his or her options until the date of the issuance to him or her of a stock certificate therefor. 

                4.6    Assignments.    The rights and benefits under this Plan may not be assigned except as provided in Sections 3.9
and 3.10. 

                4.7    Notice.    Any written notice to the Company required by any of the provisions of this Plan shall be addressed
to the secretary of the Company and shall become effective when it is received. 

                4.8    Shareholder Approval and Registration Statement.    This Plan shall be approved by the Board of Directors and
submitted to the Company's shareholders for approval. Directors may elect to participate in this Plan prior to shareholder approval and prior to filing (and effectiveness of) a registration statement
with the Securities and Exchange Commission covering the Shares to be issued upon the exercise of options. Any options granted under this Plan prior to effectiveness of the registration statement
shall not be exercisable until, and are expressly conditional upon, the effectiveness of a registration statement covering the Shares. 

                4.9    Governing Law.    This Plan and all determinations made and actions taken pursuant hereto shall be governed by
and construed in accordance with the laws of the state of Delaware. 

5

QuickLinks

Exhibit 10.19

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00047-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00047-of-00352.parquet"}]]